These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations. Basiri Z, Gholyaf M, Faridnia M, Nadi E, Bairanvand M. Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582 [Abstract] [Full Text] [Related]
5. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus. Wong KL, Liu HW, Ho K, Chan K, Wong R. J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822 [Abstract] [Full Text] [Related]
6. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Cervera R, Font J, López-Soto A, Casals F, Pallarés L, Bové A, Ingelmo M, Urbano-Márquez A. Ann Rheum Dis; 1990 Feb; 49(2):109-13. PubMed ID: 2107799 [Abstract] [Full Text] [Related]
7. The relationship of anticardiolipin antibodies to disease activity in systemic lupus erythematosus. Cooper RC, Klemp P, Stipp CJ, Brink S. Br J Rheumatol; 1989 Oct; 28(5):379-82. PubMed ID: 2790396 [Abstract] [Full Text] [Related]
9. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. Shergy WJ, Kredich DW, Pisetsky DS. J Rheumatol; 1988 Sep; 15(9):1389-94. PubMed ID: 3264338 [Abstract] [Full Text] [Related]
10. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. McHugh NJ, Moye DA, James IE, Sampson M, Maddison PJ. Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518 [Abstract] [Full Text] [Related]
11. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. López-Soto A, Cervera R, Font J, Bové A, Reverter JC, Muñoz FJ, Miret C, Espinosa G, Ordinas A, Ingelmo M. Clin Exp Rheumatol; 1997 Aug; 15(2):143-9. PubMed ID: 9196865 [Abstract] [Full Text] [Related]
15. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Loizou S, Byron MA, Englert HJ, David J, Hughes GR, Walport MJ. Q J Med; 1988 Jul; 68(255):525-31. PubMed ID: 3252304 [Abstract] [Full Text] [Related]
16. [Clinical manifestations correlated with anticardiolipin antibodies in systemic lupus erythematosus: preliminary results of a prospective study]. Galeazzi M, Sebastiani GD, Passiu G, Bellucci AM, Porzio F. Medicina (Firenze); 1990 Jul; 10(4):403-5. PubMed ID: 2099983 [Abstract] [Full Text] [Related]
17. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Samarkos M, Davies KA, Gordon C, Loizou S. Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839 [Abstract] [Full Text] [Related]
18. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. Creagh MD, Malia RG, Cooper SM, Smith AR, Duncan SL, Greaves M. J Clin Pathol; 1991 Jan; 44(1):45-7. PubMed ID: 1900070 [Abstract] [Full Text] [Related]
19. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A. J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [Abstract] [Full Text] [Related]
20. Anticardiolipin antibodies in patients with rheumatic diseases. Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Arthritis Rheum; 1987 Jul; 30(7):752-60. PubMed ID: 3619960 [Abstract] [Full Text] [Related] Page: [Next] [New Search]